Volume 31, Issue 5 (August 2020)
Studies in Medical Sciences 2020, 31(5): 335-346 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Peirouvi T, Shalizar A, Mir Yaghoobipoor S S, Meghrazi K. PROTECTIVE EFFECTS OF LACTOFERRIN AGAINST DORORUBICIN TOXICITY ON MAIN GONAD OF RAT. Studies in Medical Sciences 2020; 31 (5) :335-346
URL: http://umj.umsu.ac.ir/article-1-5080-en.html
URL: http://umj.umsu.ac.ir/article-1-5080-en.html
Department of Basic Sciences, School of Veterinary Medicine, Urmia University, Urmia, Iran (Corresponding Author) , ali_shalizar@yahoo.com
Abstract: (2872 Views)
Background & Aims: Doxorubicin has been widely used to treat solid tumors and blood malignancies, but its toxicity has limited its application. The aim of the present study was to investigate the protective effects of lactoferrin against doxorubicin toxicity on the main gonad of rats.
Materials & Methods: 24 Adult male Wistar rats were divided into four groups. Control group received physiological saline intraperitoneally and then orally, the second group received doxorubicin intraperitoneally, the third group received intraperitoneal doxorubicin, oral lactoferrin four hours after drug administration, and the fourth group received oral lactoferrin. The administration was performed weekly. After dissection, the testes of the animal were studied after tissue passage and staining.
Results: There was a statistically significant difference in mean diameter of seminiferous tubules between the control and doxorubicin groups and between the control and doxorubicin + lactoferrin groups (p≤0.05). There was also a statistically significant difference in mean diameter of seminiferous tubules between lactoferrin group and doxorubicin and doxorubicin + lactoferrin groups (p≤0.05). The mean difference between doxorubicin and doxorubicin + lactoferrin groups was also statistically significant (p≤0.05). There was a significant difference between the mean thickness of germinal epithelium between the control and doxorubicin groups and between the control and doxorubicin + lactoferrin groups (p≤0.05). There was also a statistically significant difference between lactoferrin group and doxorubicin and doxorubicin + lactoferrin groups (p≤0.05). Moreover, lactoferrin co-treatment led to a considerable increase of PCNA- and HSP70-positive cells compared to the doxorubicin-only group (p≤0.05).
Conclusion: Lactoferrin can be used to reduce the side effects of doxorubicin on reproductive organs such as the testis.
Materials & Methods: 24 Adult male Wistar rats were divided into four groups. Control group received physiological saline intraperitoneally and then orally, the second group received doxorubicin intraperitoneally, the third group received intraperitoneal doxorubicin, oral lactoferrin four hours after drug administration, and the fourth group received oral lactoferrin. The administration was performed weekly. After dissection, the testes of the animal were studied after tissue passage and staining.
Results: There was a statistically significant difference in mean diameter of seminiferous tubules between the control and doxorubicin groups and between the control and doxorubicin + lactoferrin groups (p≤0.05). There was also a statistically significant difference in mean diameter of seminiferous tubules between lactoferrin group and doxorubicin and doxorubicin + lactoferrin groups (p≤0.05). The mean difference between doxorubicin and doxorubicin + lactoferrin groups was also statistically significant (p≤0.05). There was a significant difference between the mean thickness of germinal epithelium between the control and doxorubicin groups and between the control and doxorubicin + lactoferrin groups (p≤0.05). There was also a statistically significant difference between lactoferrin group and doxorubicin and doxorubicin + lactoferrin groups (p≤0.05). Moreover, lactoferrin co-treatment led to a considerable increase of PCNA- and HSP70-positive cells compared to the doxorubicin-only group (p≤0.05).
Conclusion: Lactoferrin can be used to reduce the side effects of doxorubicin on reproductive organs such as the testis.
Type of Study: Research |
Subject:
بافت شناسی
References
1. Patil L, Balaraman R. Effect of Melatonin on Doxorubicin Induced Testicular Damage in Rats. Int J PharmTech Res 2009; 1(3): 879-84.
2. Lefrak EA, Pitha J, Rosenheim S, Gottlieb T. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973; 32: 302-14.
https://doi.org/10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2 [DOI:10.1002/1097-0142(197308)32:23.0.CO;2-2] [PMID]
3. Al-Shabanah O, Mansour M, Al-Kashef H, AL-Bekairi A. Captopril ameliorates myocardial and hematological toxicities induced by Adriamycin. Biochem Mol Biol Int 1998; 45(2): 419-27. [DOI:10.1080/15216549800202802] [PMID]
4. El-Sayyad HI, Ismail MF, Shalaby FM, Abou-El-Magd RF, Gaur RL, Fernando A, et al Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats. Int J Biol Sci 2009; 5(5): 466-73. [DOI:10.7150/ijbs.5.466] [PMID] [PMCID]
5. Adachi T, Nishimura T, Imahre H, Yamamura T. Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats. J Toxicol Sci Zoo 2000; 25(SpecialIssue):1-21. [DOI:10.2131/jts.25.SpecialIssue_1] [PMID]
6. Tsuneuari I, Kawachi M, Matsumaru T, Katsuki S. Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats. J Toxicol Sci 2000; 25:103-15. [DOI:10.2131/jts.25.SpecialIssue_103] [PMID]
7. Goodman J, Hochstein P. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochem Biophys Res Commun 1977; 77: 797- 803. [DOI:10.1016/S0006-291X(77)80048-X] [PMID]
8. Chularojmontri L, Wattanapitayakul SK, Herunsalee A, Charuchongkolwongse S, Niumsakul N, Srichairat S. Antioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity. Biol Pharm Bull 2005; 28 (7): 1165-71. [DOI:10.1248/bpb.28.1165] [PMID]
9. Prahalathan C, Selvekumar E, Varalakshmi P. Lipoic acid ameliorates adriamycin- induced testicular mitochondriopathy. Reprod Toxicol 2005; 20: 111-16. [DOI:10.1016/j.reprotox.2004.12.005] [PMID]
10. Vernet, P, Aitken RJ, Drevet JR. Antioxidant strategies in the epididymis. Mol Cell Endocrinol 2004; 216: 31-9. [DOI:10.1016/j.mce.2003.10.069] [PMID]
11. Lonnerdal B, Lyer S. Lactoferrin: molecular structure and biological function. Annu Rev Nutr 1995; 15: 93-110. [DOI:10.1146/annurev.nu.15.070195.000521] [PMID]
12. Kanyshkova TG, Buneva VN, Nevinsky GA. Lactoferrin and its biological functions. Biochemistryw (Mosc) 2001; 66: 1-7. [DOI:10.1023/A:1002817226110] [PMID]
13. Wright DG, Gallin JI. Secretory responses of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo. J Immunol 1979; 123: 285-94. [Google Scholar]
14. Wichmann L, Vaalasti T, Tuohimmaa P. Localization of lactoferrin in the male reproductive tract. Int J Androl 1989; 12: 179-86. [DOI:10.1111/j.1365-2605.1989.tb01302.x] [PMID]
15. Vorland LH. Lactoferrin a multifunctional glycoprotein. Apmis 1999; 107: 971-81. [DOI:10.1111/j.1699-0463.1999.tb01499.x] [PMID]
16. Baker EN, Baker HM, Kidd RD. Lactoferrin and transferring: functional variation on a common structural framework. Biochem Cell Biol 2002; 80: 27-34. [DOI:10.1139/o01-153] [PMID]
17. Fujita K, Matsuda E, Sekine K, Iigo M, Tsuda H. Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane treated rats. Carcinogenesis 2004; 25: 1961-6. [DOI:10.1093/carcin/bgh205] [PMID]
18. Varadhachary A, Wolf JS, Petrak K, O,Malley BW Jr, Spadaro M, Curcio C, et al. Oral Laactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int J Cancer 2004; 111: 389-403. [DOI:10.1002/ijc.20271] [PMID]
19. Bezault J, Bhimani R, Wiprovnick J, Furmanski P. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 1994; 54:2310-12. [Google Scholar]
20. Rizak SM, Zaki HF, Mina MA. Propolis attenuates doxorubicin-induced testicular toxicity in rats. Food and Chemical Toxicol 2014; 67: 176-186. [DOI:10.1016/j.fct.2014.02.031] [PMID]
21. El-sheikh AA, Morsy MA, Mahmoud MM. Protective mechanisms of coenzyme-Q10 may involve up-regulation of testicular p-glycoprotein in doxorubicin-induced toxicity. Environ Toxicol Pharmacol 2014; 37: 772-81. [DOI:10.1016/j.etap.2014.02.010] [PMID]
22. Turedi S, Yulug E, Alver A, Kutlu Ö, Kahraman C. Effects of resveratrol on doxorubicin induced testicular damage in rats. Exp Toxicol Pathol 2015; 67: 229-35. [DOI:10.1016/j.etp.2014.12.002] [PMID]
23. Olusoji MJ, Oyeyemi OM, Asenuga, Omobowale TO, Ajayi OL, Oyagbemi AA. Protective effect of galic acid on doxorubicin- induced testicular and epididymal toxicity. Andrologia 2017; 49: e12635. [DOI:10.1111/and.12635] [PMID]
24. Vijay Kranti M, Mahesh V, Srinivas P, Ganesh YV, Godwin AP, Lahkar M. Evaluation of the protective effect of silymarin on doxorubicin induced chronic testicular toxicity in rats. Int J Pharm Bio Sci 2013;4(1):437-84.
25. Ward PP, Paz E, Conneely OM. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 2005; 62: 2540-8. [DOI:10.1007/s00018-005-5369-8] [PMID]
26. Malekinejad H, Janbaz H, Razi M, Varasteh S. Preventive and protective effects of silymarin on doxorubicin-induced testicular damages correlate with changes in c-myc gene expression. Phytomedicine 2012; 19:1077-84. [DOI:10.1016/j.phymed.2012.06.011] [PMID]
27. Shalizar Jalali A, Najafi GH, Nafisi S. Protective effects of Citrullus colocynthis pulp hydroalcoholic extract against doxorubicin-induced alterations on fertilizing capacity of mouse epididymal sperms. Sci J Kurdistan Univ Med Sci 2016; 21(2): 94-102. [Google Scholar]
28. Shaerbafi R, Moradian F, Rafieye AR, Barzegar A. Isolation and Purification of Bovine Lactoferrin. J Mazandaran Univ Med Sci 2011; 21(84):44-51. [Google Scholar]
29. He Y, Lue M, Yi M, Sheng Y, Cheng Y, Zhou R, et al. Identification of a testis - enriched hest shock protein and fourteen members of Hsp70 family in the Swamp Eel. PLOS ONE 2013; 8(6): 1-10. [DOI:10.1371/journal.pone.0065269] [PMID] [PMCID]
30. Neuer A, Spandorfer SD, Giraldo P, Dieterle S, Rosenwaks Z, Witkin SS. The role of heat shock proteins in reproduction. Human Reproduction Update 2000; 6(2): 149-59. [DOI:10.1093/humupd/6.2.149] [PMID]
31. Naka KK, Vezyraki P, Kalaitzakis A, Zerikiotis S, Michalis L, Angelidis Ch. Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice. Cell Stress Chaperones 2014; 19: 853-64. [DOI:10.1007/s12192-014-0509-4] [PMID] [PMCID]
32. Tousson E, Ali EM, Ibrahim W, Mansour MA. Proliferating cell nuclear antigen as a molecular biomarker for spermatogenesis in PTU-induced hypothyroidism of rats. Reproductive Sciences 2011; 18(7): 679-86. [DOI:10.1177/1933719110395401] [PMID]
33. Zheng L, Gou M, Zhou S, Yi T, Zhong Q, Li Z, et al. Antitumor activity of monomethoxy poly(ethylene glycol)-poly(Â-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma. Oncol Rep 2011; 25: 1557-64. [Google Scholar]
34. Czeczuga-Semeniuk E, Wotczynski S, Dabrowska M, Dzieciot J, Anchim T. The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells. Folia Histochem Cytobiol 2004; 42( 4): 221-7. [Google Scholar]
35. Guven C, Taskin E, Akcakaya H. Melatonin Prevents Mitochondrial Damage Induced by Doxorubicin in Mouse Fibroblasts Through Ampk-Ppar Gamma-Dependent Mechanisms. Med Sci Monit 2016; 22: 438-46. [DOI:10.12659/MSM.897114] [PMID] [PMCID]
36. Shalizar Jalali A, Hasanzadeh S. Crataegus monogyna fruit aqueous extract as a protective agent against doxorubicin-induced reproductive toxicity in male rats. Avicenna Journal of Phytomedicine 2013; 3(2): 159-70. [PMID] [PMCID]
37. Saghaei P, Hasanzadeh S, Malekinejad H, Shalizar Jalali A. Study of the effects of lactoferrin in reduction of cyclophosphamide-induced embryotoxicity: in vitro fertilization study in mouse. J Ilam Univ Med Sci 2018; 25(5): 100-7. [DOI:10.29252/sjimu.25.5.100]
38. Arias M, Hilchie AL, Haney EF, Bolscher JGM, Hyndman ME, Hancock REW, et al. Anticancer activities of bovine and human lactoferricin-derived peptides. Biochem Cell Biol 2017; 95(1): 91-8. [DOI:10.1139/bcb-2016-0175] [PMID]
39. Legrand D. Overview of lactoferrin as a natural immune modulator. J Pediatr 2016; 173: S10-15. [DOI:10.1016/j.jpeds.2016.02.071] [PMID]
40. Bagwe S, Tharappel LJP, Kaur G, Buttar HS. Bovine colostrum: an emerging nutraceutical. J Complement Integr Med 2015; 12(3): 175-85. [DOI:10.1515/jcim-2014-0039] [PMID]
41. Sharma D, Shastri S, Sharma P. Role of lactoferrin in neonatal care: a systematic review. J Matern Fetal Neonatal Med 2017; (30): 1920-32. [DOI:10.1080/14767058.2016.1232384] [PMID]
42. Benson KF, Carter SG, Patterson KM, Patel D, Jensen GS. A novel extract from bovine colostrum whey supports anti-bacterial and anti-viral innate immune functions in vitro and in vivo. Prev Med 2012; (54): S116-23. [DOI:10.1016/j.ypmed.2011.12.023] [PMID]
43. Puddu P, Valenti P, Gessani S. Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie 2009; (91): 11-8. [DOI:10.1016/j.biochi.2008.05.005] [PMID]
44. Siqueiros-Cendón T, Arévalo-Gallegos S, Iglesias-Figueroa BF, GarcíaMontoya IA, Salazar-Martínez J, Rascón-Cruz Q. Immunomodulatory effects of lactoferrin. Acta Pharmacol 2014; (35): 557-66. [DOI:10.1038/aps.2013.200] [PMID] [PMCID]
45. Spadaro M, Caorsi C, Ceruti P, Varadhachary A, Forni G, Pericle F, et al. a major defense protein of innate immunity is a novel maturation factor for human dendritic cells. FASEB J 2008; (22): 2747-57. [DOI:10.1096/fj.07-098038] [PMID]
46. Howell S, Shalet S. Testosterone deficiency and replacement. Horm Res 2001; 56 (Suppl 1):86-92. [DOI:10.1159/000048142] [PMID]
47. Mizuno T, Sawada M, Marunouchi T, Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem Biophys Res Commun 1994; 205(3):1907-15. [DOI:10.1006/bbrc.1994.2893] [PMID]
48. Imahie H, Adachi T, Nakagawa Y, Nagasaki T, Yamamura T, Hori M. Effects of adriamycin, an anticancer drug showing testicular toxicity, on fertility in male rats. J Toxicol Sci 1995; 20(3):183-93. [DOI:10.2131/jts.20.183] [PMID]
49. Sugahara T, Ohama Y, Fukuda A, Hayashi M, Kawakubo A, Kato K. The cytotoxic effect of Eucheuma serra agglutinin (ESA) on cancer cells and its application to molecular probe for drug delivery system using lipid vesicles. Cytotechnology 2001; 36(1-3): 93-9. [DOI:10.1023/A:1014057407251] [PMID] [PMCID]
50. Ateşşahin A, Karahan I, Türk G, Gür S, Yilmaz S, Ceribaşi AO. Protective role of lycopene on cisplatin-induced changes in sperm characteristics, testicular damage and oxidative stress in rats. Reprod Toxicol 2006; 21(1):42-7. [DOI:10.1016/j.reprotox.2005.05.003] [PMID]
51. Meistrich ML. Critical components of testicular function and sensitivity to disruption. Biol Reprod 1986; 34(1):17-28. [DOI:10.1095/biolreprod34.1.17] [PMID]
52. França LR, Ogawa T, Avarbock MR, Brinster RL, Russell LD. Germ cell genotype controls cell cycle during spermatogenesis in the rat. Biol Reprod 1998;59(6):1371-7. [DOI:10.1095/biolreprod59.6.1371] [PMID]
53. Azad F, Nejati V, Shalizar-Jalali A, Najafi G, Rahmani F. Antioxidant and anti-apoptotic effects of royal jelly against nicotine-induced testicular injury in mice. Environ Toxicol 2019; 34(6):708-18. [DOI:10.1002/tox.22737] [PMID]
54. Koh PO, Kim MO. Ethanol exposure decreases cell proliferation and increases apoptosis in rat testes. J Vet Med Sci 2006; 68(10): 1013-7. [DOI:10.1292/jvms.68.1013] [PMID]
55. Selim ME, Rashed EA, Aleisa NA, Daghestani MH. The protection role of heat shock protein 70 (HSP-70) in the testes of cadmium-exposed rats. Bioformation 2012; 8(1): 58-64. [DOI:10.6026/97320630008058] [PMID] [PMCID]
56. Purandhar K, Jena PK, Prajapati B, Rajput P, Seshadri S. Understanding the Role of Heat Shock Protein Isoforms in Male Fertility, Aging and Apoptosis. World J Mens Health 2014; 32(3): 123-32. [DOI:10.5534/wjmh.2014.32.3.123] [PMID] [PMCID]
57. Baveye S, Elass E, Mazurier J, Spik G, Legrand D. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 1999; 37:281-6. [DOI:10.1515/CCLM.1999.049] [PMID]
58. Mulder AM, Connellan PA, Oliver CJ, Morris CA, Stevenson LM. Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males. Nutr Res 2008; 28: 583-9. [DOI:10.1016/j.nutres.2008.05.007] [PMID]
59. Horiuchi Y, Higuchi T, Tatsumi K, Takakura K, Fujii S, Konishi I. Lactoferrin is associated with a decrease in oocyte depletion in mice receiving cyclophosphamide. Fertil Steril 2009; 91: 2069-78. [DOI:10.1016/j.fertnstert.2008.07.024] [PMID]
60. Safaeian L, Javanmard SH, Mollanoori Y, Dana N. Cytoprotective and antioxidant effects of human lactoferrin against H2O2-induced oxidative stress in human umbilical vein endothelial cells. Adv Biomed Res 2015; 4: 188. [PMID] [PMCID]
61. Hegazy R, Salama A, Mansour D, Hassan A. Renoprotective effect of lactoferrin against chromium-induced acute kidney injury in rats: involvement of IL-18 and IGF-1 inhibition. PLoS One 2016; 11: e0151486. [DOI:10.1371/journal.pone.0151486] [PMID] [PMCID]
62. Shoji H, Oguchi S, Shinohara K, Shimizu T, Yamashiro Y. Effects of iron-unsaturated human lactoferrin on hydrogen peroxide-induced oxidative damage in intestinal epithelial cells. Pediatr Res 2007; 61: 89-92. [DOI:10.1203/01.pdr.0000250198.22735.20] [PMID]
63. El-Sawy HBI, Soliman MM, El-Shazly SA, Ali HA. Protective effects of camel milk and vitamin E against monosodium glutamate induced biochemical and testicular dysfunctions. Progress in Nutrition 2018; 20(1): 76-85. [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
